Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System: A Systematic Review.

Autor:	Azari S; Department of Health Management and Economics, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.; Research Center for Emergency and Disaster Resilience, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran., Mousavi SH; Department of Cardiology, School of Medicine and Trauma Research Center, Aja University of Medical Sciences, Tehran, Iran., Markazi Moghaddam N; Department of Health Management and Economics, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran.; Critical Care Quality Improvement Research Center, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Rezapour A; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran., Zargar Balaye Jame S; Department of Health Management and Economics, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran., Kolivand P; Department of Health Economics, Faculty of Medicine, Shahed University, Tehran, Iran., Sarabi Asiabar A; Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
Jazyk:	angličtina
Zdroj:	Medical journal of the Islamic Republic of Iran [Med J Islam Repub Iran] 2023 Apr 04; Vol. 37, pp. 16. Date of Electronic Publication: 2023 Apr 04 (Print Publication: 2023).
DOI:	10.47176/mjiri.37.16
Abstrakt:	Background: Heart Failure (HF) imposes a relevant burden and a considerable health concern, with high prevalence and mortality rates. This study was conducted to assess the cost-effectiveness of remote cardiac monitoring with the CardioMEMS Heart Failure System. Methods: In the present systematic review, several scholarly databases were searched and updated from inception up to September 20, 2022. The objective of the present review was formulated according to the patient/population, intervention, comparison and outcomes format. Mortality rate, hospitalization rate, quality-adjusted life year (QALY), total costs, and the incremental cost-effectiveness ratio regarding the use of the CardioMEMS System were the key outcomes of the present study. The quality of included studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS) checklist. Results: Finally, 5 articles were retained and analyzed in the present systematic review. All studies employed the Markov and decision tree models. Results show that the CardioMEMS system reduced mortality and hospitalization rate and created a higher QALY. In all selected countries the CardioMEMS method is a more expensive method than the standard of care (SoC), with the highest cost in the United States (US) ($201,437) and the lowest cost in the United Kingdom ($25,963), respectively. the highest willingness to pay in the US and the lowest in Italy ($100,000 and $33,000 per QALY), respectively. Results showed that the most cost per QALY for the CardioMEMS system was in the US and the lowest was in the Netherlands ($46,622 and $26,615 per QALY), respectively. Conclusion: In all selected countries, CardioMEMS is a cost-effective method for monitoring and managing pulmonary artery pressures in HF patients. Strategies such as CardioMEMS, which decrease the rate of hospitalization, are likely to be only more cost-effective in the future. Competing Interests: The authors declare that they have no competing interests. (© 2023 Iran University of Medical Sciences.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu